Clinical trial
Effect of Low-dose Lithium Therapy on Long COVID Symptoms: a Randomized Controlled Trial.
NCT05618587 is registered in ClinicalTrials.gov with State University of New York at Buffalo as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Low-dose Lithium Therapy on Long COVID Symptoms: a Randomized Controlled Trial.
- Lead sponsor
- State University of New York at Buffalo
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- November 28, 2022
- Completion date
- July 21, 2023
- Enrollment
- 52 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
long covid